SUBSCRIPTION BUNDLES

FREE

Real Money

Omega Healthcare Investors Reaches New 52-Week High (OHI)

Omega Healthcare Investors (NYSE:OHI) hit a new 52-week high Tuesday as it is currently trading at $33.10, above its previous 52-week high of $33.08 with 282,547 shares traded as of 10:06 a.m. ET. Average volume has been 1.3 million shares over the past 30 days.

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Omega Healthcare Investors (NYSE: OHI) hit a new 52-week high Tuesday as it is currently trading at $33.10, above its previous 52-week high of $33.08 with 282,547 shares traded as of 10:06 a.m. ET. Average volume has been 1.3 million shares over the past 30 days.

Omega Healthcare Investors has a market cap of $3.71 billion and is part of the financial sector and real estate industry. Shares are up 37.5% year to date as of the close of trading on Monday.

Omega Healthcare Investors, Inc. operates as a real estate investment trust (REIT) in the United States. The company invests in healthcare facilities, principally long-term healthcare facilities in the United States. The company has a P/E ratio of 29.3, above the S&P 500 P/E ratio of 17.7.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Omega Healthcare Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full Omega Healthcare Investors Ratings Report.